Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Locemia Solutions

Locemia Solutions
2012 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of needle-free, glucagon rescue treatment for severe hypoglycemia. The company develops diabetes-focused medical products for the treatment of hypoglycemia and diabetes.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 8505 Chemin Dalton
  • Montreal, Quebec H4T 1V5
  • Canada

+1 (514) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Locemia Solutions’s full profile, request a free trial.

Locemia Solutions Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 12-Oct-2015 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Locemia Solutions Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioVentures Investors Venture Capital Minority 000 0000 000000 0
Windham Venture Partners Venture Capital Minority 000 0000 000000 0

Locemia Solutions Executive Team (4)

Name Title Board
Seat
Contact
Info
Claude Piché Co-Creator, Co-Founder, President & Chief Executive Officer
Robert Coburn Chief Financial Officer
Dolores Carballo Director, Operations
Martin Lafontaine Chief Commercial Officer

Locemia Solutions Board Members (2)

Name Representing Role Since Contact
Info
Phil Willis Locemia Solutions Co-Founder & Director 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »